抗生物質医薬品有効成分(API)の世界市場2020年-2030年

◆英語タイトル:Antibiotics Active Pharmaceutical Ingredient (API) Market Forecast, Trend Analysis & Opportunity Assessment 2020-2030
◆商品コード:FMI21MA019
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2021年2月25日
◆ページ数:273
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Site Licence(同一拠点内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
Enterprisewide(複数拠点内共有可)USD10,000 ⇒換算¥1,100,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Future Market Insights社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査資料では、抗生物質医薬品有効成分(API)の世界市場を調査対象とし、エグゼクティブサマリー、市場概要、主要産業動向、市場背景、市場状況、需要分析・予測、APIタイプ別(ペニシリン系抗生物質、セファロスポリン系抗生物質、カルバペネム系抗生物質)分析、エンドユーザー別(製薬会社、医薬品製造受託機関(CMO)、医薬品開発製造受託機関(CDMO))分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。
・エグゼクティブサマリー
・市場概要
・主要産業動向
・市場背景
・市場状況
・需要分析・予測
・世界の抗生物質医薬品有効成分(API)市場規模:APIタイプ別(ペニシリン系抗生物質、セファロスポリン系抗生物質、カルバペネム系抗生物質)
・世界の抗生物質医薬品有効成分(API)市場規模:エンドユーザー別(製薬会社、医薬品製造受託機関(CMO)、医薬品開発製造受託機関(CDMO))
・世界の抗生物質医薬品有効成分(API)市場規模:地域別
・市場構造分析
・競争分析
・仮定
・調査手法
【レポートの概要】

A recent market study published by Future Market Insights (FMI) on the antibiotics API market offers global industry analysis for 2015-2019 & opportunity assessment for 2020-2030. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the antibiotics API market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may make a huge impact on the development of the antibiotics API market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the antibiotics API market in the coming years. The report provides detailed information about the current and future growth prospects of the antibiotics API market in the most comprehensive way for better understanding of readers.

Key Segments of Antibiotics API Market

Future Market Insights’ study on the antibiotics API market offers information divided into three important segments – API type, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

API Type
Penicillin Antibiotics
Ampicillin
Amoxicillin
Dicloxacillin
Penicillin G Sodium
Benzathine
Procaine
Cephalosporins
Cefotaxime
Ceftriaxone
Cefuroxime
Cefalotin
Carbapenem Antibiotics
Meropenem
Imipenem
Ertapenem

End User
Pharmaceutical Companies
Contract Manufacturing Organizations (CMOs)
Contract Development & Manufacturing Organizations (CDMOs)

Region
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

Chapter 1 – Executive Summary

The report commences with the executive summary of the antibiotics API market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the antibiotics API market as well as the key trends impacting the market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy and product definition of the antibiotics API market, in this chapter, which help readers understand basic information about antibiotics API.

Chapter 3 – Key Market Trends

This section highlights the key trends impacting the antibiotics API market, which will help readers understand the current trends and their impact on market growth.

Chapter 4 – Market Background

This chapter explains the key macroeconomic factors that are expected to influence the growth of the antibiotics API market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the antibiotics API market, which include the drivers, restraints, and opportunity analysis. This chapter is expected to enable readers to understand the factors that are propelling the growth of the antibiotics API market, as well as those that are likely to hamper the growth of the antibiotics API market. The opportunity analysis for antibiotics API will help readers understand the market opportunities, based on which they can plan their strategies.

Chapter 5 – Market Context

This chapter explains the promotional strategies, key regulations for product launch in various countries along with usage analysis that are expected to influence the growth of the antibiotics API market during the forecast period.

Chapter 6 – Global Antibiotics API Market Value (US$) Analysis 2015-2019 and Forecast 2020-2030

This section explains the global market value analysis and forecast for the antibiotics API market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030).

Chapter 7 – Global Antibiotics API Market Analysis (2015-2019) & Opportunity Assessment (2020-2030), By API Type

Based on API type, the antibiotics API market is segmented into penicillin antibiotics, cephalosporins, and carbapenem antibiotics. In this chapter, readers can find information about a detailed analysis of the market by different types of antibiotics API and their growth over the forecast period.

Chapter 8 – Global Antibiotics API Market Analysis 2015-2019 & Opportunity Assessment, 2020-2030, By End User

Based on end user, the antibiotics API market is segmented into pharmaceutical companies, contract manufacturing organizations (CMOs), and contract development & manufacturing organizations (CDMOs). In this chapter, readers can find information on market attractive analysis based on end user.

Chapter 9 – Global Antibiotics API Market Analysis 2015-2019 & Opportunity Assessment 2020-2030, By Region

This chapter explains how the antibiotics API market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).

Chapter 10 – North America Antibiotics API Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter includes a detailed analysis of the growth of the North America antibiotics API market along with the country-wise assessment including the U.S. and Canada. Readers can also find key takeaways of this region, and market growth based on API type, end user and country of antibiotics API in the North American region.

Chapter 11 – Latin America Antibiotics API Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter includes the growth prospects of the antibiotics API market in leading countries such as Brazil, Mexico, and the rest of Latin America. Readers can find thorough information about the growth parameters of the Latin America antibiotics API market during 2020-2030.

Chapter 12 – Europe Antibiotics API Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

Important growth prospects of the antibiotics API market based on API type, end user, and country in several European countries such as the U.K., Germany, France, Italy, Spain, Russia, BENELUX, and Rest of Europe are included in this chapter.

Chapter 13 – South Asia Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030

India, Indonesia, Malaysia, Thailand, and the rest of South Asia are the leading countries/regions in South Asia that are the prime subjects of assessment to obtain the growth prospects of the South Asia antibiotics API market, in this chapter, readers can find thorough information about the growth parameters of the South Asia antibiotics API market during 2030.

Chapter 14 – East Asia Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030

Detailed information about factors such as incremental opportunity, Y-O-Y growth, and regional trends that are impacting the growth of the East Asia antibiotics API market are included in this chapter. It also includes the growth prospects of the antibiotics API market in leading East Asian countries such as China, Japan, and South Korea.

Chapter 15 – Oceania Antibiotics API Market Analysis 2015–2019 and Forecast 2020–2030

This chapter consists of important parameters that have a huge impact on the growth of the antibiotics API market in Oceania, based on market segmentation, during the forecast period. The chapter also provides an overview of the drivers, restraints, and trends in the Oceania antibiotics API market.

Chapter 16 – MEA Antibiotics API Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides information on how the antibiotics API market will grow in the major countries in MEA region, such as GCC Countries, South Africa, Northern Africa, Turkey and Rest of MEA during 2020-2030.

Chapter 17 – Key and Emerging Countries Antibiotics API Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides information on how the antibiotics API market will grow in the major countries across the world during 2020-2030.

Chapter 18 – Market Structure Analysis

This chapter covers the market analysis of competitors based on revenue tiers, single point view of portfolio across industry segments, and their relative market position.

Chapter 19 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Antibiotics API market, along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Players featured in the antibiotics API market report include Sandoz International GmbH, Centrient Pharmaceuticals, CordenPharma International, ACS DOBFAR SPA, Nanjing Dorra Pharmaceutical Technology Co. Ltd., DAEWOONG PHARMACEUTICAL CO. LTD., Parabolic Drugs Ltd., Penam Laboratories Ltd., ASIATIC DRUGS & PHARMACEUTICALS PVT. LTD., Fresenius Kabi, The United Laboratories International Holdings Limited, Aurobindo Pharma Limited, Unimark Remedies Ltd., Savior Lifetec, Shenzhen Haibin Pharmaceutical Co., Ltd., Sterile India Pvt. Ltd., Zhejiang Jiuzhou Pharmaceutical Co. Ltd., and Kyongbo Pharm

Chapter 20 – Assumptions and Acronyms Used

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 21 – Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the antibiotics API market.

Sources and Primary Research Splits (%)

Industry Interactions

Key Designations

C – Level Executives
Marketing Directors
Product Managers
Business Development Officers
Production Managers
Procurement Heads
Sales Executives
Stakeholder Category

Distributors
Traders
Raw Material Suppliers
Industry Experts
Consumptions
Questions

Current Market Dynamics and Challenges
Yesteryear Trends
Market Characteristics
Market Performance and Growth Quadrants
Competition Structure and Market Structure
Strategic Growth Initiatives
Near-term and Long-term Market Growth Prospects
Market Segment Splits and Authenticity
Opinions on Market Projections and Validity of Assumptions
References Catalogue

Industry Publications
World Health Organizations (WHO)
National Institute of Health (NIH)
Factiva
Company Press Releases
Annual Reports and Investor Presentations
Research Papers
Government Websites and Publications
Company Websites,
Morningstar

【レポートの目次】

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation /Development Trends

3.3. COVID19 Crisis Analysis

3.3.1. COVID19 and Impact Analysis

3.3.2. 2020 Market Scenario

3.3.3. Recovery Scenario- Short term, Midterm and Long Term Impact

4. Market Background

4.1. Macro-Economic Factors

4.1.1. Global GDP Growth Outlook

4.1.2. Global Healthcare Expenditure Outlook

4.2. Forecast Factors – Relevance & Impact

4.2.1. Research and Developmental Activities

4.2.2. Product Formulation Advancement

4.2.3. Key Players Historical Growth

4.2.4. Market Consolidation Activities

4.2.5. Growing Investment by Key Players in Product Development

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunity Analysis

5. Market Context

5.1. Product USPs/ Features

5.2. Product Adoption / Usage Analysis

5.3. Regulatory Scenario

5.4. Supply-Chain Analysis

5.5. Consumption, By API Type (in Tons per Annum)

5.6. Pricing Analysis, BY API Type

6. Global Antibiotics API Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020–2030

6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

6.2.1. Y-o-Y Growth Trend Analysis

6.2.2. Absolute $ Opportunity Analysis

7. Global Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030, By API Type

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By API Type, 2015 – 2019

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By API Type, 2020–2030

7.3.1. Penicillin Antibiotics

7.3.1.1. Ampicillin

7.3.1.2. Amoxicillin

7.3.1.3. Dicloxacillin

7.3.1.4. Penicillin G Sodium

7.3.1.5. Benzathine

7.3.1.6. Procaine

7.3.2. Cephalosporins

7.3.2.1. Cefotaxime

7.3.2.2. Ceftriaxone

7.3.2.3. Cefuroxime

7.3.2.4. Cefalotin

7.3.3. Carbapenem Antibiotics

7.3.3.1. Meropenem

7.3.3.2. Imipenem

7.3.3.3. Ertapenem

8. Global Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030, By End User

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By End User, 2015 – 2019

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020–2030

8.3.1. Pharmaceutical Companies

8.3.2. Contract Manufacturing Organizations (CMOs)

8.3.3. Contract Development & Manufacturing Organizations (CDMOs)

8.4. Market Attractiveness Analysis By End User

9. Global Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030, by Region

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 – 2019

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020–2030

9.3.1. North America

9.3.2. Latin America

9.3.3. Europe

9.3.4. East Asia

9.3.5. South Asia

9.3.6. Oceania

9.3.7. Middle East and Africa (MEA)

9.4. Market Attractiveness Analysis By Region

10. North America Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030

10.3.1. By Country

10.3.1.1. U.S.

10.3.1.2. Canada

10.3.2. By API Type

10.3.3. By End User

10.4. Market Attractiveness Analysis

10.5. Key Market Participants – Intensity Mapping

10.6. Drivers and Restraints – Impact Analysis

11. Latin America Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030

11.3.1. By Country

11.3.1.1. Brazil

11.3.1.2. Mexico

11.3.1.3. Argentina

11.3.1.4. Rest of Latin America

11.3.2. By API Type

11.3.3. By End User

11.4. Market Attractiveness Analysis

11.5. Key Market Participants – Intensity Mapping

11.6. Drivers and Restraints – Impact Analysis

12. Europe Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030

12.3.1. By Country

12.3.1.1. Germany

12.3.1.2. Italy

12.3.1.3. France

12.3.1.4. U.K.

12.3.1.5. Spain

12.3.1.6. BENELUX

12.3.1.7. Russia

12.3.1.8. Rest of Europe

12.3.2. By API Type

12.3.3. By End User

12.4. Market Attractiveness Analysis

12.5. Key Market Participants – Intensity Mapping

12.6. Drivers and Restraints – Impact Analysis

13. South Asia Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030,

13.3.1. By Country

13.3.1.1. India

13.3.1.2. Thailand

13.3.1.3. ASEAN countries

13.3.1.4. Rest of South Asia

13.3.2. By API Type

13.3.3. By End User

13.4. Market Attractiveness Analysis

13.5. Key Market Participants – Intensity Mapping

13.6. Drivers and Restraints – Impact Analysis

14. East Asia Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030

14.3.1. By Country

14.3.1.1. China

14.3.1.2. Japan

14.3.1.3. South Korea

14.3.2. By API Type

14.3.3. By End User

14.4. Market Attractiveness Analysis

14.5. Key Market Participants – Intensity Mapping

14.6. Drivers and Restraints – Impact Analysis

15. Oceania Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030

15.3.1. By Country

15.3.1.1. Australia

15.3.1.2. New Zealand

15.3.2. By API Type

15.3.3. By End User

15.4. Market Attractiveness Analysis

15.5. Key Market Participants – Intensity Mapping

15.6. Drivers and Restraints – Impact Analysis

16. Middle East and Africa Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030

16.3.1. By Country

16.3.1.1. GCC Countries

16.3.1.2. South Africa

16.3.1.3. Rest of Middle East and Africa

16.3.2. By API Type

16.3.3. By End User

16.4. Market Attractiveness Analysis

16.5. Key Market Participants – Intensity Mapping

16.6. Drivers and Restraints – Impact Analysis

17. Key and Emerging Countries Antibiotics API Market Analysis 2015-2019 and Forecast 2020-2030

17.1. Introduction

17.1.1. Market Value Proportion Analysis, By Key Countries

17.1.2. Global Vs. Country Growth Comparison

17.2. U.S. Antibiotics API Market Analysis

17.2.1. By API Type

17.2.2. By End User

17.3. Canada Antibiotics API Market Analysis

17.3.1. By API Type

17.3.2. By End User

17.4. Mexico Antibiotics API Market Analysis

17.4.1. By API Type

17.4.2. By End User

17.5. Brazil. Antibiotics API Market Analysis

17.5.1. By API Type

17.5.2. By End User

17.6. Argentina Antibiotics API Market Analysis

17.6.1. By API Type

17.6.2. By End User

17.7. U.K. Antibiotics API Market Analysis

17.7.1. By API Type

17.7.2. By End User

17.8. Germany Antibiotics API Market Analysis

17.8.1. By API Type

17.8.2. By End User

17.9. France Antibiotics API Market Analysis

17.9.1. By API Type

17.9.2. By End User

17.10. Italy Antibiotics API Market Analysis

17.10.1. By API Type

17.10.2. By End User

17.11. Spain Antibiotics API Market Analysis

17.11.1. By API Type

17.11.2. By End User

17.12. Russia Antibiotics API Market Analysis

17.12.1. By API Type

17.12.2. By End User

17.13. China Antibiotics API Market Analysis

17.13.1. By API Type

17.13.2. By End User

17.14. Japan Antibiotics API Market Analysis

17.14.1. By API Type

17.14.2. By End User

17.15. South Korea Antibiotics API Market Analysis

17.15.1. By API Type

17.15.2. By End User

17.16. India Antibiotics API Market Analysis

17.16.1. By API Type

17.16.2. By End User

17.17. Thailand Antibiotics API Market Analysis

17.17.1. By API Type

17.17.2. By End User

17.18. ASEAN Antibiotics API Market Analysis

17.18.1. By API Type

17.18.2. By End User

17.19. Australia Antibiotics API Market Analysis

17.19.1. By API Type

17.19.2. By End User

17.20. New Zealand Antibiotics API Market Analysis

17.20.1. By API Type

17.20.2. By End User

17.21. GCC Countries Antibiotics API Market Analysis

17.21.1. By API Type

17.21.2. By End User

17.22. Turkey Antibiotics API Market Analysis

17.22.1. By API Type

17.22.2. By End User

17.23. South Africa Antibiotics API Market Analysis

17.23.1. By API Type

17.23.2. By End User

18. Market Structure Analysis

18.1. Market Analysis by Tier of Companies

18.2. Market Concentration

18.3. Market Share Analysis of Top Players

18.4. Market Presence Analysis

18.4.1. By Regional Footprint of Players

18.4.2. API Type Footprint by Players

18.4.3. Channel Footprint by Players

19. Competition Analysis

19.1. Competition Dashboard

19.2. Competition Benchmarking

19.3. Competition Deep Dive (Tentative List)

19.3.1. Sandoz International GmbH

19.3.1.1. Overview

19.3.1.2. Product Portfolio

19.3.1.3. Key Financial

19.3.1.4. Sales Footprint

19.3.1.5. Strategic Overview

19.3.2. Centrient Pharmaceuticals

19.3.2.1. Overview

19.3.2.2. Product Portfolio

19.3.2.3. Key Financial

19.3.2.4. Sales Footprint

19.3.2.5. Strategic Overview

19.3.3. CordenPharma International

19.3.3.1. Overview

19.3.3.2. Product Portfolio

19.3.3.3. Key Financial

19.3.3.4. Sales Footprint

19.3.3.5. Strategic Overview

19.3.4. ACS DOBFAR SPA

19.3.4.1. Overview

19.3.4.2. Product Portfolio

19.3.4.3. Key Financial

19.3.4.4. Sales Footprint

19.3.4.5. Strategic Overview

19.3.5. Nanjing Dorra Pharmaceutical Technology Co. Ltd.

19.3.5.1. Overview

19.3.5.2. Product Portfolio

19.3.5.3. Key Financial

19.3.5.4. Sales Footprint

19.3.5.5. Strategic Overview

19.3.6. DAEWOONG PHARMACEUTICAL CO. LTD.

19.3.6.1. Overview

19.3.6.2. Product Portfolio

19.3.6.3. Key Financial

19.3.6.4. Sales Footprint

19.3.6.5. Strategic Overview

19.3.7. Parabolic Drugs Ltd.

19.3.7.1. Overview

19.3.7.2. Product Portfolio

19.3.7.3. Key Financial

19.3.7.4. Sales Footprint

19.3.7.5. Strategic Overview

19.3.8. Penam Laboratories Ltd.

19.3.8.1. Overview

19.3.8.2. Product Portfolio

19.3.8.3. Key Financial

19.3.8.4. Sales Footprint

19.3.8.5. Strategic Overview

19.3.9. ASIATIC DRUGS & PHARMACEUTICALS PVT. LTD.

19.3.9.1. Overview

19.3.9.2. Product Portfolio

19.3.9.3. Key Financial

19.3.9.4. Sales Footprint

19.3.9.5. Strategic Overview

19.3.10. Fresenius Kabi

19.3.10.1. Overview

19.3.10.2. Product Portfolio

19.3.10.3. Key Financial

19.3.10.4. Sales Footprint

19.3.10.5. Strategic Overview

19.3.11. The United Laboratories International Holdings Limited

19.3.11.1. Overview

19.3.11.2. Product Portfolio

19.3.11.3. Key Financial

19.3.11.4. Sales Footprint

19.3.11.5. Strategic Overview

19.3.12. Aurobindo Pharma Limited

19.3.12.1. Overview

19.3.12.2. Product Portfolio

19.3.12.3. Key Financial

19.3.12.4. Sales Footprint

19.3.12.5. Strategic Overview

19.3.13. Unimark Remedies Ltd.

19.3.13.1. Overview

19.3.13.2. Product Portfolio

19.3.13.3. Key Financial

19.3.13.4. Sales Footprint

19.3.13.5. Strategic Overview

19.3.14. Savior Lifetec

19.3.14.1. Overview

19.3.14.2. Product Portfolio

19.3.14.3. Key Financial

19.3.14.4. Sales Footprint

19.3.14.5. Strategic Overview

19.3.15. Shenzhen Haibin Pharmaceutical Co., Ltd.

19.3.15.1. Overview

19.3.15.2. Product Portfolio

19.3.15.3. Key Financial

19.3.15.4. Sales Footprint

19.3.15.5. Strategic Overview

19.3.16. Sterile India Pvt. Ltd.

19.3.16.1. Overview

19.3.16.2. Product Portfolio

19.3.16.3. Key Financial

19.3.16.4. Sales Footprint

19.3.16.5. Strategic Overview

19.3.17. Zhejiang Jiuzhou Pharmaceutical Co. Ltd.

19.3.17.1. Overview

19.3.17.2. Product Portfolio

19.3.17.3. Key Financial

19.3.17.4. Sales Footprint

19.3.17.5. Strategic Overview

19.3.18. Kyongbo Pharm

19.3.18.1. Overview

19.3.18.2. Product Portfolio

19.3.18.3. Key Financial

19.3.18.4. Sales Footprint

19.3.18.5. Strategic Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Table 01: Global Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type

Table 02: Global Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 03: Global Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region

Table 04: North America Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 05: North America Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type

Table 06: North America Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 07: Latin America Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 08: Latin America Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type

Table 09: Latin America Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 10: Europe Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 11: Europe Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type

Table 12: Europe Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 13: South Asia Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 14: South Asia Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type

Table 15: South Asia Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 16: East Asia Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 17: East Asia Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type

Table 18: East Asia Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 19: Oceania Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 20: Oceania Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type

Table 21: Oceania Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 22: Middle East and Africa Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 23: Middle East and Africa Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By API Type

Table 24: Middle East and Africa Antibiotics API Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Figure 01: Global Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 02: Global Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 03: Global Antibiotics API Market Absolute $ Opportunity, 2020 - 2030

Figure 04: Global Antibiotics API Market Share Analysis (%), By API Type, 2020-2030

Figure 05: Global Antibiotics API Market Y-o-Y Analysis (%), By API Type, 2020-2030

Figure 06: Global Antibiotics API Market Attractiveness Analysis, By API Type, 2020-2030

Figure 07: Global Antibiotics API Market Share Analysis (%), By End User, 2020-2030

Figure 08: Global Antibiotics API Market Y-o-Y Analysis (%), By End User, 2020-2030

Figure 09: Global Antibiotics API Market Attractiveness Analysis by End User, 2020-2030

Figure 10: Global Antibiotics API Market Share Analysis (%), By Region, 2020-2030

Figure 11: Global Antibiotics API Market Y-o-Y Analysis (%), By Region, 2020-2030

Figure 12: Global Antibiotics API Market Attractiveness Analysis by Region, 2020-2030

Figure 13: North America Antibiotics API Market Value Share, By API Type, 2020 (E)

Figure 14: North America Antibiotics API Market Value Share, By End User, 2020 (E)

Figure 15: North America Antibiotics API Market Value Share, By Country, 2020 (E)

Figure 16: North America Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 17: North America Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 18: North America Antibiotics API Market Attractiveness Analysis by API Type, 2020 – 2030

Figure 19: North America Antibiotics API Market Attractiveness Analysis by End User, 2020- 2030

Figure 20: North America Antibiotics API Market Attractiveness Analysis by Country, 2020 - 2030

Figure 21: Latin America Antibiotics API Market Value Share, By API Type, 2020 (E)

Figure 22: Latin America Antibiotics API Market Value Share, By End User, 2020 (E)

Figure 23: Latin America Antibiotics API Market Value Share, By Country, 2020 (E)

Figure 24: Latin America Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 25: Latin America Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 26: Latin America Antibiotics API Market Attractiveness Analysis by API Type, 2020 - 2030

Figure 27: Latin America Antibiotics API Market Attractiveness Analysis by End User, 2020 -2030

Figure 28: Latin America Antibiotics API Market Attractiveness Analysis by Country, 2020-2030

Figure 29: Europe Antibiotics API Market Value Share, By API Type, 2020 (E)

Figure 30: Europe Antibiotics API Market Value Share, By End User, 2020 (E)

Figure 31: Europe Antibiotics API Market Value Share, By Country, 2020 (E)

Figure 32: Europe Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 33: Europe Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 34: Europe Antibiotics API Market Attractiveness Analysis by API Type, 2020-2030

Figure 35: Europe Antibiotics API Market Attractiveness Analysis by End User, 2020-2030

Figure 36: Europe Antibiotics API Market Attractiveness Analysis by Country, 2020-2030

Figure 37: South Asia Antibiotics API Market Value Share, By API Type, 2020 (E)

Figure 38: South Asia Antibiotics API Market Value Share, By End User, 2020 (E)

Figure 39: South Asia Antibiotics API Market Value Share, By Country, 2020 (E)

Figure 40: South Asia Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 41: South Asia Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 42: South Asia Antibiotics API Market Attractiveness Analysis, By API Type, 2020-2030

Figure 43: South Asia Antibiotics API Market Attractiveness Analysis, By End User, 2020-2030

Figure 44: South Asia Antibiotics API Market Attractiveness Analysis, By Country, 2020-2030

Figure 45: East Asia Antibiotics API Market Value Share, By API Type, 2020 (E)

Figure 46: East Asia Antibiotics API Market Value Share, By End User, 2020 (E)

Figure 47: East Asia Antibiotics API Market Value Share, By Country, 2020 (E)

Figure 48: East Asia Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 49: East Asia Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 50: East Asia Antibiotics API Market Attractiveness Analysis by API Type, 2020-2030

Figure 51: East Asia Antibiotics API Market Attractiveness Analysis by End User, 2020-2030

Figure 52: East Asia Antibiotics API Market Attractiveness Analysis by Country, 2020-2030

Figure 53: Oceania Antibiotics API Market Value Share, By API Type, 2020 (E)

Figure 54: Oceania Antibiotics API Market Value Share, By End User, 2020 (E)

Figure 55: Oceania Antibiotics API Market Value Share, By Country, 2020 (E)

Figure 56: Oceania Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 57: Oceania Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 58: Oceania Antibiotics API Market Attractiveness Analysis, By API Type, 2020-2030

Figure 59: Oceania Antibiotics API Market Attractiveness Analysis, By End User, 2020-2030

Figure 60: Oceania Antibiotics API Market Attractiveness Analysis by Country, 2020-2030

Figure 61: Middle East and Africa Antibiotics API Market Value Share, By API Type, 2020 (E)

Figure 62: Middle East and Africa Antibiotics API Market Value Share, By End User, 2020 (E)

Figure 63: Middle East and Africa Antibiotics API Market Value Share, By Country, 2020 (E)

Figure 64: Middle East and Africa Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 65: Middle East and Africa Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 66: Middle East and Africa Antibiotics API Market Attractiveness Analysis by API Type, 2020-2030

Figure 67: Middle East and Africa Antibiotics API Market Attractiveness Analysis, By End User, 2020-2030

Figure 68: Middle East and Africa Antibiotics API Market Attractiveness Analysis by Country, 2020-2030

Figure 69: U.S. Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 70: U.S. Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 71: U.S. Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 72: U.S Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 73: U.S Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 74: Canada Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 75: Canada Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 76: Canada Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 77: Canada Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 78: Canada Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 79: Mexico Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 80: Mexico Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 81: Mexico Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 82: Mexico Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 83: Mexico Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 84: Brazil Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 85: Brazil Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 86: Brazil Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 87: Brazil Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 88: Brazil Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 89: Argentina Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 90: Argentina Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 91: Argentina Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 92: Argentina Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 93: Argentina Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 94: U.K. Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 95: U.K. Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 96: U.K. Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 97: U.K. Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 98: U.K. Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 99: Germany Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 100: Germany Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 101: Germany Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 102: Germany Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 103: Germany Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 104: France Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 105: France Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 106: France Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 107: France Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 108: France Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 109: Italy Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 110: Italy Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 111: Italy Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 112: Italy Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 113: Italy Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 114: Spain Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 115: Spain Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 116: Spain Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 117: Spain Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 118: Spain Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 119: Russia Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 120: Russia Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 121: Russia Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 122: Russia Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 123: Russia Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 124: China Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 125: China Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 126: China Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 127: China Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 128: China Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 129: Japan Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 130: Japan Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 131: Japan Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 132: Japan Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 133: Japan Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 134: South Korea Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 135: South Korea Antibiotics API Market Value Share, By Aend User, 2020 & 2030

Figure 136: South Korea Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 137: South Korea Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 138: South Korea Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 139: India Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 140: India Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 141: India Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 142: India Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 143: India Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 144: Thailand Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 145: Thailand Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 146: Thailand Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 147: Thailand Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 148: Thailand Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 149: Malaysia Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 150: Malaysia Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 151: Malaysia Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 152: Malaysia Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 153: Malaysia Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 154: Indonesia Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 155: Indonesia Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 156: Indonesia Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 157: Indonesia Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 158: Indonesia Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 159: Australia Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 160: Australia Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 161: Australia Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 162: Australia Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 163: Australia Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 164: New Zealand Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 165: New Zealand Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 166: New Zealand Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 167: New Zealand Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 168: New Zealand Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 169: GCC Countries Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 170: GCC Countries Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 171: GCC Countries Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 172: GCC Countries Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 173: GCC Countries Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 174: Turkey Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 175: Turkey Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 176: Turkey Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 177: Turkey Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 178: Turkey Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

Figure 179: South Africa Antibiotics API Market Value Share, By API Type, 2020 & 2030

Figure 180: South Africa Antibiotics API Market Value Share, By End User, 2020 & 2030

Figure 181: South Africa Antibiotics API Market Value Analysis (US$ Mn), 2020 & 2030

Figure 182: South Africa Antibiotics API Market Value Analysis (US$ Mn), 2015-2019

Figure 183: South Africa Antibiotics API Market Value Forecast (US$ Mn), 2020-2030

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[抗生物質医薬品有効成分(API)の世界市場2020年-2030年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆